https://stock.noler.com/us/stock/reshape-lifesciences-inc https://stock.noler.com/us/stock/reshape-lifesciences-inc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/accounts-payable https://stock.noler.com/us/stock/reshape-lifesciences-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/accounts-payable-other-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/accounts-payable-trade-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/accounts-receivable https://stock.noler.com/us/stock/reshape-lifesciences-inc/accounts-receivable-net https://stock.noler.com/us/stock/reshape-lifesciences-inc/accretion-expense https://stock.noler.com/us/stock/reshape-lifesciences-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/accrued-insurance-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/accrued-liabilities-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/accumulated-depreciation https://stock.noler.com/us/stock/reshape-lifesciences-inc/acquisition-pro-forma-information-earnings-or-loss-of-acquiree-since-acquisition-date-actual https://stock.noler.com/us/stock/reshape-lifesciences-inc/acquisition-pro-forma-information-revenue-of-acquiree-since-acquisition-date-actual https://stock.noler.com/us/stock/reshape-lifesciences-inc/acquisitions https://stock.noler.com/us/stock/reshape-lifesciences-inc/additional-paid-in-capital https://stock.noler.com/us/stock/reshape-lifesciences-inc/adjustment-of-warrants-granted-for-services https://stock.noler.com/us/stock/reshape-lifesciences-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/reshape-lifesciences-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/amortization https://stock.noler.com/us/stock/reshape-lifesciences-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/reshape-lifesciences-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/reshape-lifesciences-inc/aoci https://stock.noler.com/us/stock/reshape-lifesciences-inc/asset-impairment-charges https://stock.noler.com/us/stock/reshape-lifesciences-inc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/reshape-lifesciences-inc/available-for-sale-change-in-net-unrealized-holding-gain-loss-net-of-tax https://stock.noler.com/us/stock/reshape-lifesciences-inc/available-for-sale-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/available-for-sale-fair-value-disclosure https://stock.noler.com/us/stock/reshape-lifesciences-inc/available-for-sale-gross-unrealized-gain https://stock.noler.com/us/stock/reshape-lifesciences-inc/available-for-sale-gross-unrealized-losses https://stock.noler.com/us/stock/reshape-lifesciences-inc/buybacks-payments-for-repurchase-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/reshape-lifesciences-inc/buybacks-payments-for-repurchase-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/reshape-lifesciences-inc/capital-expenditures https://stock.noler.com/us/stock/reshape-lifesciences-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/reshape-lifesciences-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/reshape-lifesciences-inc/cash-and-equivalents https://stock.noler.com/us/stock/reshape-lifesciences-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/reshape-lifesciences-inc/cash-flow-breakdown https://stock.noler.com/us/stock/reshape-lifesciences-inc/cash-provided-by-used-in-investing-activities-discontinued-operations https://stock.noler.com/us/stock/reshape-lifesciences-inc/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/reshape-lifesciences-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/reshape-lifesciences-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/reshape-lifesciences-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/reshape-lifesciences-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/reshape-lifesciences-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/reshape-lifesciences-inc/common-stock-value https://stock.noler.com/us/stock/reshape-lifesciences-inc/comprehensive-income https://stock.noler.com/us/stock/reshape-lifesciences-inc/concentration-risk-percentage https://stock.noler.com/us/stock/reshape-lifesciences-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/reshape-lifesciences-inc/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/reshape-lifesciences-inc/convertible-debt-fair-value-disclosures https://stock.noler.com/us/stock/reshape-lifesciences-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/reshape-lifesciences-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/reshape-lifesciences-inc/convertible-subordinated-debt-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/cost-of-goods-sold https://stock.noler.com/us/stock/reshape-lifesciences-inc/cost-of-revenue https://stock.noler.com/us/stock/reshape-lifesciences-inc/cost-of-revenue-2 https://stock.noler.com/us/stock/reshape-lifesciences-inc/cost-of-services https://stock.noler.com/us/stock/reshape-lifesciences-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/reshape-lifesciences-inc/current-assets https://stock.noler.com/us/stock/reshape-lifesciences-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/reshape-lifesciences-inc/current-liabilities https://stock.noler.com/us/stock/reshape-lifesciences-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/reshape-lifesciences-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/reshape-lifesciences-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/reshape-lifesciences-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/reshape-lifesciences-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/reshape-lifesciences-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/reshape-lifesciences-inc/debt-face-amount https://stock.noler.com/us/stock/reshape-lifesciences-inc/debt-fair-value https://stock.noler.com/us/stock/reshape-lifesciences-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/reshape-lifesciences-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/reshape-lifesciences-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/reshape-lifesciences-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/reshape-lifesciences-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/reshape-lifesciences-inc/debt-repaid https://stock.noler.com/us/stock/reshape-lifesciences-inc/debt-unamortized-discount https://stock.noler.com/us/stock/reshape-lifesciences-inc/debt-unamortized-discount-noncurrent https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-assets-operating-loss-carryforwards-not-subject-to-expiration https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-assets-state-taxes https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-assets-tax-deferred-expense https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-liabilities-goodwill-and-intangible-assets https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/reshape-lifesciences-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/reshape-lifesciences-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/reshape-lifesciences-inc/depreciation https://stock.noler.com/us/stock/reshape-lifesciences-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/reshape-lifesciences-inc/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/reshape-lifesciences-inc/derivative-liabilities https://stock.noler.com/us/stock/reshape-lifesciences-inc/disposal-group-including-discontinued-operation-assets-noncurrent https://stock.noler.com/us/stock/reshape-lifesciences-inc/disposal-group-including-discontinued-operation-consideration https://stock.noler.com/us/stock/reshape-lifesciences-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/reshape-lifesciences-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/reshape-lifesciences-inc/effective-tax-rate https://stock.noler.com/us/stock/reshape-lifesciences-inc/embedded-derivative-fair-value-of-embedded-derivative-liability https://stock.noler.com/us/stock/reshape-lifesciences-inc/embedded-derivative-gain-loss-on-embedded-derivative-net https://stock.noler.com/us/stock/reshape-lifesciences-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/equity-issuance-dollar-amount-per-share https://stock.noler.com/us/stock/reshape-lifesciences-inc/equity-issuance-per-share-amount https://stock.noler.com/us/stock/reshape-lifesciences-inc/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/reshape-lifesciences-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/reshape-lifesciences-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/reshape-lifesciences-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/reshape-lifesciences-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/reshape-lifesciences-inc/financing-cash-flow https://stock.noler.com/us/stock/reshape-lifesciences-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/reshape-lifesciences-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/reshape-lifesciences-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/reshape-lifesciences-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/reshape-lifesciences-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/reshape-lifesciences-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/reshape-lifesciences-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/reshape-lifesciences-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/reshape-lifesciences-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/reshape-lifesciences-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/reshape-lifesciences-inc/fixtures-and-equipment-gross https://stock.noler.com/us/stock/reshape-lifesciences-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/reshape-lifesciences-inc/form-d-other https://stock.noler.com/us/stock/reshape-lifesciences-inc/form-d-stocks https://stock.noler.com/us/stock/reshape-lifesciences-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/reshape-lifesciences-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/reshape-lifesciences-inc/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/reshape-lifesciences-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/reshape-lifesciences-inc/general-and-administrative-expense https://stock.noler.com/us/stock/reshape-lifesciences-inc/goodwill https://stock.noler.com/us/stock/reshape-lifesciences-inc/goodwill-and-intangible-asset-impairment https://stock.noler.com/us/stock/reshape-lifesciences-inc/goodwill-gross https://stock.noler.com/us/stock/reshape-lifesciences-inc/goodwill-impaired-accumulated-impairment-loss https://stock.noler.com/us/stock/reshape-lifesciences-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/reshape-lifesciences-inc/gross-profit https://stock.noler.com/us/stock/reshape-lifesciences-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/reshape-lifesciences-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/reshape-lifesciences-inc/income-loss-from https://stock.noler.com/us/stock/reshape-lifesciences-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/reshape-lifesciences-inc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/reshape-lifesciences-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/reshape-lifesciences-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/reshape-lifesciences-inc/income-tax https://stock.noler.com/us/stock/reshape-lifesciences-inc/income-tax-examination-penalties-and-interest-expense https://stock.noler.com/us/stock/reshape-lifesciences-inc/income-taxes-paid https://stock.noler.com/us/stock/reshape-lifesciences-inc/increase-decrease-in-accounts-and-other-receivables https://stock.noler.com/us/stock/reshape-lifesciences-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/reshape-lifesciences-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/reshape-lifesciences-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/reshape-lifesciences-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/reshape-lifesciences-inc/increase-decrease-in-fair-value-of-unhedged-derivative-instruments https://stock.noler.com/us/stock/reshape-lifesciences-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/reshape-lifesciences-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/reshape-lifesciences-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/reshape-lifesciences-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/reshape-lifesciences-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/reshape-lifesciences-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/reshape-lifesciences-inc/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/reshape-lifesciences-inc/insider-transactions-other https://stock.noler.com/us/stock/reshape-lifesciences-inc/insider-transactions-other/purchases https://stock.noler.com/us/stock/reshape-lifesciences-inc/insider-transactions-preferred https://stock.noler.com/us/stock/reshape-lifesciences-inc/insider-transactions-preferred/purchases https://stock.noler.com/us/stock/reshape-lifesciences-inc/insider-transactions-preferred/sales https://stock.noler.com/us/stock/reshape-lifesciences-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/reshape-lifesciences-inc/insider-transactions-warrants https://stock.noler.com/us/stock/reshape-lifesciences-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/reshape-lifesciences-inc/intangible-assets-gross-excluding-goodwill https://stock.noler.com/us/stock/reshape-lifesciences-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/reshape-lifesciences-inc/interest-expense https://stock.noler.com/us/stock/reshape-lifesciences-inc/interest-expense-on-debt https://stock.noler.com/us/stock/reshape-lifesciences-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/reshape-lifesciences-inc/interest-paid https://stock.noler.com/us/stock/reshape-lifesciences-inc/interest-paid-net https://stock.noler.com/us/stock/reshape-lifesciences-inc/interest-payable-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/inventory https://stock.noler.com/us/stock/reshape-lifesciences-inc/inventory-adjustments https://stock.noler.com/us/stock/reshape-lifesciences-inc/inventory-finished-goods https://stock.noler.com/us/stock/reshape-lifesciences-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/reshape-lifesciences-inc/inventory-gross https://stock.noler.com/us/stock/reshape-lifesciences-inc/inventory-lifo-reserve https://stock.noler.com/us/stock/reshape-lifesciences-inc/inventory-noncurrent https://stock.noler.com/us/stock/reshape-lifesciences-inc/inventory-raw-materials https://stock.noler.com/us/stock/reshape-lifesciences-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/reshape-lifesciences-inc/inventory-supplies-net-of-reserves https://stock.noler.com/us/stock/reshape-lifesciences-inc/inventory-work-in-process https://stock.noler.com/us/stock/reshape-lifesciences-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/reshape-lifesciences-inc/investing-cash-flow https://stock.noler.com/us/stock/reshape-lifesciences-inc/investment-income-amortization-of-discount https://stock.noler.com/us/stock/reshape-lifesciences-inc/investment-income-interest https://stock.noler.com/us/stock/reshape-lifesciences-inc/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/reshape-lifesciences-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/reshape-lifesciences-inc/legal-fees https://stock.noler.com/us/stock/reshape-lifesciences-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/reshape-lifesciences-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/reshape-lifesciences-inc/litigation-settlement-expense https://stock.noler.com/us/stock/reshape-lifesciences-inc/long-term-debt https://stock.noler.com/us/stock/reshape-lifesciences-inc/long-term-debt-fair-value https://stock.noler.com/us/stock/reshape-lifesciences-inc/long-term-debt-percentage-bearing-fixed-interest-rate https://stock.noler.com/us/stock/reshape-lifesciences-inc/long-term-notes-payable https://stock.noler.com/us/stock/reshape-lifesciences-inc/minority-interest-ownership-percentage-by-noncontrolling-owners https://stock.noler.com/us/stock/reshape-lifesciences-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/reshape-lifesciences-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/reshape-lifesciences-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/reshape-lifesciences-inc/net-change-in-cash https://stock.noler.com/us/stock/reshape-lifesciences-inc/net-income https://stock.noler.com/us/stock/reshape-lifesciences-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/reshape-lifesciences-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/reshape-lifesciences-inc/new-accounting-pronouncement-or-change-in-accounting-principle-cumulative-effect-of-change-on-equity-or-net-assets https://stock.noler.com/us/stock/reshape-lifesciences-inc/non-hedging-derivatives-gain-loss-net https://stock.noler.com/us/stock/reshape-lifesciences-inc/noncash-or-part-noncash-acquisition-value-of-assets-acquired https://stock.noler.com/us/stock/reshape-lifesciences-inc/notes-payable https://stock.noler.com/us/stock/reshape-lifesciences-inc/notes-payable-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/notes-reduction https://stock.noler.com/us/stock/reshape-lifesciences-inc/number-of-operating-segments https://stock.noler.com/us/stock/reshape-lifesciences-inc/number-of-reporting-units https://stock.noler.com/us/stock/reshape-lifesciences-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/reshape-lifesciences-inc/oci-net-of-tax https://stock.noler.com/us/stock/reshape-lifesciences-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-cash-flow https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-expenses https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-income https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-assets https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-cost https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-liability https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-liability-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-payments https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-payments-due https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-payments-due-in-rolling-year-four https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-payments-due-in-rolling-year-three https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-payments-due-next-rolling-twelve-months https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/reshape-lifesciences-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/reshape-lifesciences-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/other-current-assets https://stock.noler.com/us/stock/reshape-lifesciences-inc/other-intangible-assets-net https://stock.noler.com/us/stock/reshape-lifesciences-inc/other-noncash-expense https://stock.noler.com/us/stock/reshape-lifesciences-inc/other-noncash-income-expense https://stock.noler.com/us/stock/reshape-lifesciences-inc/other-noncurrent-assets https://stock.noler.com/us/stock/reshape-lifesciences-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/reshape-lifesciences-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/other-receivables-net-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/other-significant-noncash-transaction-value-of-consideration-received https://stock.noler.com/us/stock/reshape-lifesciences-inc/paid-in-capital-other https://stock.noler.com/us/stock/reshape-lifesciences-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/reshape-lifesciences-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/reshape-lifesciences-inc/paid-in-capital-stock-split https://stock.noler.com/us/stock/reshape-lifesciences-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/reshape-lifesciences-inc/payments-for-capital-improvements https://stock.noler.com/us/stock/reshape-lifesciences-inc/payments-of-capital-distribution https://stock.noler.com/us/stock/reshape-lifesciences-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/reshape-lifesciences-inc/payments-of-financing-costs https://stock.noler.com/us/stock/reshape-lifesciences-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/reshape-lifesciences-inc/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/reshape-lifesciences-inc/payments-to-acquire-held-to-maturity-securities https://stock.noler.com/us/stock/reshape-lifesciences-inc/preferred-shares-facts https://stock.noler.com/us/stock/reshape-lifesciences-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/reshape-lifesciences-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/reshape-lifesciences-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/reshape-lifesciences-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/reshape-lifesciences-inc/preferred-stock-value https://stock.noler.com/us/stock/reshape-lifesciences-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/prepaid-insurance https://stock.noler.com/us/stock/reshape-lifesciences-inc/pretax-income https://stock.noler.com/us/stock/reshape-lifesciences-inc/proceeds-from-bank-debt https://stock.noler.com/us/stock/reshape-lifesciences-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/reshape-lifesciences-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/reshape-lifesciences-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/reshape-lifesciences-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/reshape-lifesciences-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/reshape-lifesciences-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/reshape-lifesciences-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/reshape-lifesciences-inc/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/reshape-lifesciences-inc/proceeds-from-sale-and-maturity-of-held-to-maturity-securities https://stock.noler.com/us/stock/reshape-lifesciences-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/reshape-lifesciences-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/reshape-lifesciences-inc/proceeds-from-subordinated-short-term-debt https://stock.noler.com/us/stock/reshape-lifesciences-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/reshape-lifesciences-inc/profit-loss https://stock.noler.com/us/stock/reshape-lifesciences-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/reshape-lifesciences-inc/property-plant-and-equipment-other https://stock.noler.com/us/stock/reshape-lifesciences-inc/property-plant-equipment https://stock.noler.com/us/stock/reshape-lifesciences-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/reshape-lifesciences-inc/public-float https://stock.noler.com/us/stock/reshape-lifesciences-inc/purchase-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/reshape-lifesciences-inc/repayments-of-convertible-debt https://stock.noler.com/us/stock/reshape-lifesciences-inc/repayments-of-debt https://stock.noler.com/us/stock/reshape-lifesciences-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/reshape-lifesciences-inc/repayments-of-subordinated-short-term-debt https://stock.noler.com/us/stock/reshape-lifesciences-inc/research-and-development https://stock.noler.com/us/stock/reshape-lifesciences-inc/restricted-cash https://stock.noler.com/us/stock/reshape-lifesciences-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/reshape-lifesciences-inc/retained-earnings https://stock.noler.com/us/stock/reshape-lifesciences-inc/revenue https://stock.noler.com/us/stock/reshape-lifesciences-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/reshape-lifesciences-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/reshape-lifesciences-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/reshape-lifesciences-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/reshape-lifesciences-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/reshape-lifesciences-inc/sales-revenue-services-net https://stock.noler.com/us/stock/reshape-lifesciences-inc/secured-debt-current https://stock.noler.com/us/stock/reshape-lifesciences-inc/secured-long-term-debt https://stock.noler.com/us/stock/reshape-lifesciences-inc/sga-expense https://stock.noler.com/us/stock/reshape-lifesciences-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/reshape-lifesciences-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/reshape-lifesciences-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/reshape-lifesciences-inc/share-based-goods-and-nonemployee-services-transaction-quantity-of-securities-issued https://stock.noler.com/us/stock/reshape-lifesciences-inc/share-price https://stock.noler.com/us/stock/reshape-lifesciences-inc/shareholders-equity https://stock.noler.com/us/stock/reshape-lifesciences-inc/shares-authorized https://stock.noler.com/us/stock/reshape-lifesciences-inc/shares-issued https://stock.noler.com/us/stock/reshape-lifesciences-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/reshape-lifesciences-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/reshape-lifesciences-inc/shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/reshape-lifesciences-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/reshape-lifesciences-inc/shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/reshape-lifesciences-inc/short-term-borrowings https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-award-percentage-of-outstanding-stock-maximum https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-award-shares-issued-in-period https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-based-compensation https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-redeemed-or-called-shares https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-redeemed-or-called-value https://stock.noler.com/us/stock/reshape-lifesciences-inc/stock-split-ratio https://stock.noler.com/us/stock/reshape-lifesciences-inc/stockholders-equity-other https://stock.noler.com/us/stock/reshape-lifesciences-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/reshape-lifesciences-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/reshape-lifesciences-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/reshape-lifesciences-inc/tax-rate-reconciliation-deductions https://stock.noler.com/us/stock/reshape-lifesciences-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/reshape-lifesciences-inc/tax-rate-reconciliation-nondeductible-expense-impairment-losses https://stock.noler.com/us/stock/reshape-lifesciences-inc/tax-rate-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/reshape-lifesciences-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/reshape-lifesciences-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/reshape-lifesciences-inc/total-assets https://stock.noler.com/us/stock/reshape-lifesciences-inc/total-contract-liability https://stock.noler.com/us/stock/reshape-lifesciences-inc/total-liabilities https://stock.noler.com/us/stock/reshape-lifesciences-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/reshape-lifesciences-inc/total-long-term-debt https://stock.noler.com/us/stock/reshape-lifesciences-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/reshape-lifesciences-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/reshape-lifesciences-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/reshape-lifesciences-inc/warrant-down-round-feature-increase-decrease-in-equity-amount https://stock.noler.com/us/stock/reshape-lifesciences-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/reshape-lifesciences-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/reshape-lifesciences-inc/weighted-average-number-of-shares-issued-basic